Blood donors may no longer be needed in the future after scientists showed it was possible to create blood from stem cells. The 20 year project could pave the way for an unlimited number of blood and immune cells for transplants, simply by reprogramming a patient’s own skin cells. The research, reported in the journal...
Category: <span>Miscellaneous</span>
THE MEN AND WOMEN WHO ARE TRYING TO BRING DOWN CANCER ARE STARTING TO JOIN FORCES RATHER THAN WORK ALONE. TOGETHER, THEY ARE WINNING A FEW OF THE BATTLES AGAINST THE WORLD’S FIERCEST DISEASE. FOR THIS UNPRECEDENTED SPECIAL REPORT, WE VISITED ELITE CANCER RESEARCH CENTERS AROUND THE COUNTRY TO FIND OUT WHERE WE ARE IN THE WAR
I. Precision Medicine: What Is Cancer, Really? When you visit St. Jude Children’s Research Hospital in Memphis, Tennessee, you expect to feel devastated. It starts in the waiting room. Oh, here we go with the little red wagons, you think, observing the cattle herd of them rounded up by the entrance to the Patient Care Center. Oh, here...
FDA proposes that doctors learn about acupuncture for pain management
Chiropractors and acupuncturists who have lobbied for a bigger role in treating pain have won a preliminary endorsement from federal health officials. The Food and Drug Administration released proposed changes Wednesday to its blueprint on educating health care providers about treating pain. The guidelines now recommend that doctors get information about chiropractic care and acupuncture as therapies that might help patients avoid...
Health Insurance In America: Here Are Pre-Existing Conditions Under The GOP Health Plan
U.S. President Donald Trump’s 105th day in the White House was made memorable as the House voted to overhaul the 2010 Affordable Care Act, more popularly known as Obamacare. In his opening address on Thursday (May 4), House Speaker Paul Ryan, a staunch supporter of the GOP health bill – the American Health Care Act –...
The Endoplasmic Reticulum: Networking Inside the Cell
Like a successful business networker, a cell’s endoplasmic reticulum (ER) is the structure that reaches out—quite literally—to form connections with many different parts of a cell. In several important ways, the ER enables those other parts, or organelles, to do their jobs. Exciting new images of this key member of the cellular workforce may clarify...
Medicare recipients using rehabilitation services report major functional improvements
The latest study by Assistant Professor Nancy Gell (center) shows that regardless of demographics senior citizens benefit equally from the use of rehabilitation services offered through Medicare. A new study showing significant patient-reported functional improvement among Medicare recipients who utilize rehabilitation services offers hope for America’s 65-and-older set, which is expected to double by...
‘Mind-blowing’ study of people born with one hand reveals scientists have misunderstood how the brain works for centuries
Study suggests brain areas are organised by functions rather than body parts This could fundamentally change our understanding of how the brain works Study looked at one-handed people as they performed different tasks The area of the brain associated with the subjects’ missing hand was activated when they used different body parts A ‘mind-blowing’ discovery...
Autism Speaks issues special report
Autism Speaks today issued the first in a series of annual, in-depth reports on special topics in autism. Autism and Health: Advances in Understanding and Treating the Health Conditions that Frequently Accompany Autism gathers into one comprehensive report the most authoritative research and the latest guidelines on treatment and support of children and adults with...
More evidence Parkinson’s starts in the gut: Removing a section of digestive tract nerve lowers your risk by 40%, study claims
A new study provides more evidence that Parkinson’s disease starts in the gut Scientists studied patients who had vagotomies – a removal of part of a nerve which extends from the brainstem to the abdomen Those who had the trunk removed were 40% less likely to develop the disease More evidence has emerged suggesting that...
The evolution of proteasome inhibition: A personal journey from early research to approval
My 16 plus years at Takeda Oncology have given me the opportunity to participate in and contribute to the evolution of treatment for multiple myeloma, a rare cancer that affects nearly 230,000 people around the world, according to five-year prevalence estimates.1 While the disease remains incurable, we have made important advances in research and development in recent years....